Neuroone Medical Technologies Corp (NMTC) — Cash Flow Reinvestment Rate
Neuroone Medical Technologies Corp (NMTC) has a Cash Flow Reinvestment Rate of 0.23x as of December 2024, reinvesting $48.83K (capex $24.42K plus investments $-24.42K) from operating cash flow of $208.05K. See cash generation quality of Neuroone Medical Technologies Corp to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuroone Medical Technologies Corp Cash Flow Reinvestment Rate (2009–2009)
Historical reinvestment intensity for Neuroone Medical Technologies Corp across 1 annual periods. For the full cash flow conversion analysis, see Neuroone Medical Technologies Corp (NMTC) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Neuroone Medical Technologies Corp (2009–2009)
Year-by-year capital reinvestment analysis for Neuroone Medical Technologies Corp. See Neuroone Medical Technologies Corp leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2009 | 0.00x | $0.00 | $6.18K | $0.00 | — |